AtriCure, Inc.
News and overview for AtriCure, Inc.
AtriCure Reports Third Quarter 2009 Financial Results [Press Release]
Business Wire | 18 days 16 hours 54 minutes ago
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced revenues of $13.3 million for its seasonally light third quarter. The company reported positive adjusted EBITDA, a non-GAAP measure, of $0.7 million for the quarter, representing the third consecutive quarter of positive adjusted EBITDA and year-to-date adjusted EBITDA of $1.7 million.
AtriCure Announces Tentative Settlement with the Department of Justice [Press Release]
Business Wire | 18 days 17 hours 14 minutes ago
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it has reached a tentative agreement, subject to completion and approval of a written settlement agreement, with the Department of Justice (DOJ) to resolve the issues raised in the DOJ’s investigation and the related qui tam complaint regarding the marketing of the Company’s surgical ablation devices. The agreement includes AtriCure’s assertion that the Company and i...
Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement [Press Release]
PRNewswire | 18 days 1 hour 15 minutes ago
...Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement PRNewswire...Grant Morris, announced today that AtriCure, Inc., a medical device company specializing...the relator in the case against AtriCure, which was filed in the United...
AtriCure to Present at Canaccord Adams Cardiovascular Conference [Press Release]
Business Wire | 20 days 8 hours 42 minutes ago
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it will participate in the Canaccord Adams Cardiovascular Conference at Hotel Nikko in San Francisco on Tuesday, November 10, 2009. David J. Drachman, President and Chief Executive Officer, is scheduled to present at 3:30 p.m. Pacific Time.
AtriCure to Announce Third Quarter 2009 Financial Results [Press Release]
Business Wire | 37 days 16 hours 59 minutes ago
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, will release its financial results for the third quarter ended September 30, 2009 on Wednesday, November 4, 2009 and management will host a conference call at 10:00 a.m. Eastern Time. A live webcast of the conference call will be available from the investor relations page of AtriCure’s corporate web site, www.atricure.com.
AtriCure pays $3.8M to settle with US
Cincinnati Enquirer, The | 18 days 14 hours 54 minutes ago
WEST CHESTER TWP. - Surgical device maker AtriCure Inc. this morning disclosed it has reached a tentative $3.8 million settlement with the Department of Justice to resolve issues surrounding marketing some of its devices.
Reportlinker Adds Global Cardiovascular Devices Investment Opportunities Analysis and Forecasts to 2012 Report [Press Release]
Business Wire | 40 days 14 hours 47 minutes ago
Reportlinker.com announces that a new market research report is available in its catalogue.
AtriCure suit settlement boosts stock
American City Business Journals | 18 days 12 hours 57 minutes ago
AtriCure Inc. stayed in the red for its third quarter, with a loss that missed analysts’ expectations, but its announcement of a settlement in a whistleblower suit boosted its stock Wednesday morning.
Canaccord Adams hosts 29th Annual Global Growth Conference: August 11-13, 2009: Boston [Press Release]
PRNewswire | 108 days 10 hours 23 minutes ago
- Investor conference features 240 small and mid-cap companies in six sectors - - 50+ next-generation companies will present at the Private Company Showcase - - Knowledge sessions will feature key topics in targeted coverage areas -
Corporate Watch
Wall Street Journal, The | 17 days 23 hours 54 minutes ago
Software Maker Cuts An Additional 800 Jobs Microsoft Corp. said Wednesday it was laying off another 800 employees, expanding the scale of a cost-reduction program it announced at the beginning of the year.
Prolifiq potential
American City Business Journals | 42 days 2 hours 6 minutes ago
Prolifiq Software Inc. is on pace to match last year’s 52 percent revenue growth by selling sales communication software to high-tech and digital media companies.
Reportlinker Adds Cardiac Rhythm Management (CRM) Devices Report [Press Release]
PRNewswire | 75 days 13 hours 22 minutes ago
...Electrophysiology, Biosense Webster, Inc., Boston Scientific Corporation...GMBH & Co. KG, Medtronic, Inc., Medtronic CryoCath LP...Healthcare, St. Jude Medical, Inc., and Sorin Group. Market...Bipolar Ablation Clamp System of AtriCure Obtains FDA 510(k) Clearance...
12 Results
Sign up for AdvaMed SmartBrief
Company Overview
| Company: | AtriCure, Inc. |
|---|---|
| Industry: | Medical Devices |
| Website: | http://www.atricure.com |
If your heart thumps to the beat of a different drummer, AtriCure wants to clamp down on that activity. The medical device maker has developed a system used in the treatment of atrial fibrillation (AF), a common type of heart arrhythmia. Its primary product, the Isolator bipolar ablation system, allows surgeons to manipulate clamps designed for both open-heart and minimally-invasive procedures. Although the FDA has cleared Isolator for the ablation of cardiac tissue, none of AtriCure's products have received approval specifically for the treatment of AF. Nevertheless, cardiothoracic surgeons have adopted the system to create lesions in the tissue to block electrical impulses that cause quivering in the heart.
Key Numbers
| Sales in U.S. Dollars (mil.) | 55.3 (2008) |
|---|---|
| One-year % Growth in Sales | 14.4 (2008) |
| Net Income in U.S. Dollars (mil.) | -10.2 (2008) |
| One-year % Growth in Net Income | 0.0 (2008) |
| Number of Employees | 200 (2008) |
| One-year % Growth in Number of Employees | 0.0 (2008) |
| Fiscal Year-End | December |